UNSPSC 51283512: Meticillin sodium

This classification denotes a penicillin antibiotic with the molecular formula C17H19N2O6S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AO9YF4MN30, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, monohydrate, (2s-(2alpha,5alpha,6beta))- but more generally known as methicillin sodium, which bears US NIH Compound Identifier 23675.

European Medicines Agency schedules Meticillin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03264MIG. Most nations, for tariff and trade purposes, schedule meticillin sodium under HS 29411090. SMILES: CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3C(CCCC3OC)OC)C(=O)[O-])C.[NA+].

UNSPSC 51283512 Meticillin sodium is a Commodity code that represents a single antibiotic product line, yet recent state and local solicitations tagged under this code show minimal direct procurement of meticillin sodium itself. Instead, the code appears in opportunities focused on broader pharmaceutical and medical supply categories—generic multi-source drugs, naloxone and drug deactivation systems, and first-aid supplies for emergency response. State and local governments issuing under or near this code include county health departments, state health and human services agencies, city fire departments, and cooperative purchasing alliances spanning multiple jurisdictions. The actual purchasing activity reflects demand for emergency response pharmaceuticals, OTC products, and medical consumables rather than meticillin sodium as a discrete line item.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026 (due March 26, 2026) to establish multi-year contracts for generic pharmaceuticals and OTC products distributed across state and local facilities, requiring vendors to work through three authorized wholesalers and meet FDA compliance, cGMP certification, and Drug Supply Chain Security Act requirements. Seminole County, Florida released an IFB on June 30, 2026 for naloxone and drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually) with quarterly deliveries to the county community health building and a response deadline of July 26, 2023. The City of Tampa's Purchasing Department solicited sealed bids for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division (estimated $700,000 contract, due March 13, 2026), designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas Health and Human Services Commission issued an RFI in April 2026 regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program to gather vendor capabilities for direct contracting outside traditional pharmacy benefit managers and wholesalers. The code shows activity primarily in cooperative purchasing and emergency response supply chains rather than concentrated demand for meticillin sodium as a standalone pharmaceutical line.